American Century Companies’s Acumen Pharmaceuticals ABOS Stock Holding History

American Century Companies's ABOS Position: Q2 2026 in Review

American Century Companies increased its Acumen Pharmaceuticals (ABOS) stake by 35% in Q2 2026, buying an estimated $15.3K and bringing the position to 24,136 shares worth $64.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2860.

American Century Companies first reported a position in ABOS in Q3 2023 and has held it in 8 quarters since. The position peaked at $140K in Q1 2024. 96 funds tracked by Wall St. Rank hold ABOS as of Q2 2026.

• American Century Companies held 24,136 shares of Acumen Pharmaceuticals worth $64.4K as of Q2 2026.
• American Century Companies bought 6,207 Acumen Pharmaceuticals shares in Q2 2026, an estimated $15.3K.
• Acumen Pharmaceuticals made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2860 holding.
• American Century Companies first reported a position in Acumen Pharmaceuticals in Q3 2023 and has held it in 8 quarters since.
• American Century Companies's Acumen Pharmaceuticals position peaked at $140K in Q1 2024.
• 96 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.